Home
Storia in 1 fonti
Exclusive: Waypoint Bio raises $20M to run three CAR-T trials in China
New York City-based startup Waypoint Bio has raised $20 million in series A financing to test multiple cell therapies in China.
Raccontata da
endpoints.news
Timeline cronologica
- ·
Exclusive: Waypoint Bio raises $20M to run three CAR-T trials in China
New York City-based startup Waypoint Bio has raised $20 million in series A financing to test multiple cell therapies in China.
- ·
Exclusive: China gene editing startup YolTech raises $70M to move CRISPR therapies forward
Yoltech Therapeutics, one of China’s most prolific gene editing companies has raised its biggest round of funding ahead of plans to go public in Hong Kong.